Motiva Preserve vs Conventional Breast Augmentation

What actually differs

Conventional breast augmentation often relies on electrocautery for dissection and hemostasis. The Preserve approach minimizes cautery and dissects the prefascial plane with balloon and separator tools, aiming to reduce thermal and tissue trauma (Motiva — Preserve). The implant itself is also different — an FDA-approved Motiva device.

Tissue handling and capsular contracture

Bleeding, hematoma, and tissue irritation are reported among risk factors for capsular contracture in systematic reviews (Risk factors for capsular contracture after breast implant surgery: a systematic review — JPRAS (2018); Overview of risk factors and prevention of capsular contracture: a systematic review — Cureus (2020)). Reducing thermal injury is therefore a plausible direction, though no technique eliminates the risk, and general implant-surgery risks remain (FDA — Risks and Complications).

Surface technology

Implant surface topography influences the foreign body response (Nature Biomedical Engineering, 2021). Motiva's SmoothSilk/SilkSurface is positioned in this context, but surface alone does not determine an individual result.

What the evidence does and doesn't show

Multi-year outcome analyses of Motiva Ergonomix implants describe cohort results (3-year, PRS 2018; 4-year interim, Aesthetic Plast Surg 2021). These can inform expectations but are averages, not a promise of any individual outcome. A balanced reading — benefits and limits — is the honest basis for a decision.